Trial · NCT03409107
Adverse events246
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
121 to 140 of 246
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Diabetic gastropathy | Gastrointestinal disorders | Placebo | 1 | 306 | 1 |
| serious | Diabetic gastropathy | Gastrointestinal disorders | Daprodustat | 0 | 308 | 0 |
| serious | Diarrhoea | Gastrointestinal disorders | Placebo | 0 | 306 | 0 |
| serious | Diarrhoea | Gastrointestinal disorders | Daprodustat | 1 | 308 | 1 |
| serious | Large intestine polyp | Gastrointestinal disorders | Placebo | 1 | 306 | 1 |
| serious | Large intestine polyp | Gastrointestinal disorders | Daprodustat | 0 | 308 | 0 |
| serious | Nausea | Gastrointestinal disorders | Placebo | 0 | 306 | 0 |
| serious | Nausea | Gastrointestinal disorders | Daprodustat | 1 | 308 | 1 |
| serious | Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 306 | 1 |
| serious | Acute pulmonary oedema | Respiratory, thoracic and mediastinal disorders | Daprodustat | 3 | 308 | 3 |
| serious | Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 306 | 1 |
| serious | Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | Daprodustat | 1 | 308 | 1 |
| serious | Acute interstitial pneumonitis | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 306 | 0 |
| serious | Acute interstitial pneumonitis | Respiratory, thoracic and mediastinal disorders | Daprodustat | 1 | 308 | 1 |
| serious | Bronchial hyperreactivity | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 306 | 1 |
| serious | Bronchial hyperreactivity | Respiratory, thoracic and mediastinal disorders | Daprodustat | 0 | 308 | 0 |
| serious | Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 306 | 0 |
| serious | Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | Daprodustat | 1 | 308 | 1 |
| serious | Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | Placebo | 1 | 306 | 1 |
| serious | Interstitial lung disease | Respiratory, thoracic and mediastinal disorders | Daprodustat | 0 | 308 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03409107/events?page=7